We present clinical-pathological and cytogenetic evaluation of a patient with Philadelphia-chromosome negative CML/MPD harboring a t(9;22)(p24;q11.2) resulting in BCR-JAK2 fusion. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.